Rocket ... just speculating, but I would think DM could cut that deal ($5c pps) at any time, but hasn't yet. If the warrants riase fails or failed, then perhaps that starts looking better, depending on the "true" nature of the cash position, ongoing operational costs, future, and confidence in funding sources?

As much as the "players" have taken advantage of the ebbs & tides, the pps bounced back remarkably after the drop following TLD failure. There are obviously investors (possibly limited to "in-the-know" types) who still see a significant opportunity, just not the broader market which only sees study failure, a long road ahead, and extreme financial instability/risk for RVX.

I am frustrated, but still have hope and mild confidence that somepody will pick up the RVX, and IP, technology, and leadership position at some point ... yeah, on some days I am ready to vote an emphatic YES to $5 pps, ... but I am still holding out "hope" for multiple times that number.

This is nerve-wracking ... but I sure would like to see the warrants offer fill up at least enough coffers to wait for clear FDA/EMA/other direction, which will in turn determine much of the present and near future valuation, at least. Whether it is break-through (& P4?), bolt-on, or a whole new P3 is of large HUGE consequence financially and for confidence in the future ... in my mind, at least. 

I just don't see how either RVX or a BP partner can adequately assess the valuation and risk without the latest regulatory information and risk? ... which "shoould" be known imminently, within a few months presumably?

I would think there are contingency deals on the table for multiple scenarios, good/bad/ugly?  

But back to your $5c pps point, many people would make money at that price even if it wasn't the goal, and some would make a lot of money. I tthink Hepa and Eastern had large buys around $2.60c? Hepa would make over $100m if I did my napkin math correctly. 

With the safety profile, unmet needs, potential markets, IP, leadership opportunity, data & close miss on the TLD/FLD ... let's hope that the very WORST case is $4-5c pps, to a BP. I could be very wrong though, especially if simply run out of cash, and the vultures all go vulture with nobody jumping in to close a bargain deal which still makes most investors feel "okay" or even "good" ..... 

The silence is deafening ...